Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid - Copyright BRENDAN MCDERMID(Reuters)

By Reuters

Published on 12/07/2019 - 17:34•Updated 26/04/2024 - 04:34

Comments

(Reuters) - Johnson & Johnson <JNJ.N> said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body's immune system.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)

Comments

You might also like